Applying DART to Drug Screening

What is DART?

Direct analysis in real-time (DART) is a mass spectrometry technique that uses an ion source to analyze samples of molecules via the interaction of the ions with the molecules.

Drug Laboratory

Image Credit: Gorodenkoff/Shutterstock.com

DART has become established in numerous industries due to its versatility, simplicity, and speed in analyzing a wide variety of samples.

Solids, liquids, and gases can be investigated by DART, which can take place in ambient environments, obtaining precise mass measurements of the samples.

Fields such as; drug control, environmental research, food, forensics, fragrance, pharmacology, quality control, security, and others, have adopted the DART technique into various applications to explore a wide range of substances both as whole items and as traces on surfaces.

Developing DART for drug screening applications

The DART technique has been beneficial for drug screening. Recent years have seen the increasing need for effective and rapid screening techniques that can reliably analyze and detect the increasing number of illegal drugs currently in circulation.

There has been increasing workload demand in analytical laboratories, leading to the development of improved analytical techniques to assess a broad range of samples.

In the late 2000s, DART was explored for applicability to drug screening techniques. DART had previously been demonstrated as a reliable technique for identifying a variety of substances, from the metabolites of pharmaceuticals to toxins and explosives.

One of the first studies to explore the potential of DART in drug screening investigated the effectiveness of DART in screening forensic evidence for illicit drugs.

The study established a lower detection limit in DART, demonstrating effectiveness at screening for solid dosage forms of controlled substances which led to the Virginia Department of Forensic Science incorporating DART.

A more recent study analyzed the effectiveness of combining DART with a chromatographic technique to develop a system of rapidly screening for drugs.

The study investigated the success of DART in screening for known drug standards, as well as for analyzing samples of unknown drug concentrations that had been confiscated from a UK music festival.

The results showed that DART was able to recognize the known drug samples, as well as being able to identify the unknown samples.

Numerous studies have investigated the use of DART in combination with time-of-flight (TOF) mass spectrometry.

The results of combining the two techniques were that drug screening accuracy was improved, the workflow was reduced, as were cycle times and reduced process time as there is no requirement for sample preparation. Overall, the combined technique was concluded to enhance laboratory productivity and accuracy in results.

A further study comparing the effectiveness of DART paired with TOF against other firmly established drug screening techniques such as thin-layer chromatography, color tests, and ultraviolet spectroscopy demonstrated that the previously established techniques were useful for categorizing samples, however, DART combined with TOF was highly specific in identification of the substance.

Summary

DART is a useful method for enhancing drug screening techniques, increasing accuracy, reducing testing time, with the capability of assessing and identifying a range of substances. The use of the technique is predicted to be utilized by forensic labs and law enforcement for rapid, on the spot screening of substances.

References:

  • Cody, R. B., Laramée, J. A., & Durst, H. D. (2005). Versatile new ion source for the analysis of materials in open air under ambient conditions. Analytical Chemistry, 77(8), 2297-2302.
  • Lian, R., Wu, Z., Lv, X., Rao, Y., Li, H., Li, J., Wang, R., Ni, C. and Zhang, Y. (2017). Rapid screening of abused drugs by direct analysis in real-time (DART) coupled to time-of-flight mass spectrometry (TOF-MS) combined with ion mobility spectrometry (IMS). Forensic Science International, 279, pp.268-280.
  • National Research Council. (2009). Strengthening forensic science in the United States: a path forward. National Academies Press.
  • Steiner, R. R. (2018). Use of DART-TOF-MS for screening drugs of abuse. Analysis of drugs of abuse (pp. 59-68). Humana Press, New York, NY.
  • Steiner, R. and Larson, R. (2009). Validation of the Direct Analysis in Real-Time Source for Use in Forensic Drug Screening. Journal of Forensic Sciences, 54(3), pp.617-622.

Further Reading

Last Updated: Sep 12, 2022

Sarah Moore

Written by

Sarah Moore

After studying Psychology and then Neuroscience, Sarah quickly found her enjoyment for researching and writing research papers; turning to a passion to connect ideas with people through writing.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Moore, Sarah. (2022, September 12). Applying DART to Drug Screening. AZoLifeSciences. Retrieved on November 25, 2024 from https://www.azolifesciences.com/article/Applying-DART-to-Drug-Screening.aspx.

  • MLA

    Moore, Sarah. "Applying DART to Drug Screening". AZoLifeSciences. 25 November 2024. <https://www.azolifesciences.com/article/Applying-DART-to-Drug-Screening.aspx>.

  • Chicago

    Moore, Sarah. "Applying DART to Drug Screening". AZoLifeSciences. https://www.azolifesciences.com/article/Applying-DART-to-Drug-Screening.aspx. (accessed November 25, 2024).

  • Harvard

    Moore, Sarah. 2022. Applying DART to Drug Screening. AZoLifeSciences, viewed 25 November 2024, https://www.azolifesciences.com/article/Applying-DART-to-Drug-Screening.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.